React Congress
React Congress
React Congress
WelcomeAttendees
  • Registration
  • Abstract information
  • Venue
  • Berlin
Program
  • Full Program
  • Time table
SpeakersSponsors

Full Program

RE(ACT) Congress & IRDiRC Conference 2023

This program is subject to change without notice at any time.

WEDNESDAY, MARCH 15th

Session A, 13h30 to 17, « Diagnostic, WGS, artificial intelligence, new technologies »

  • Martina Cornel, NL « Sequencing for early diagnosis in neonatal screening and health care »
  • Julia Foreman, UK « DECIPHER – Enabling the sharing of rare disease phenotype-linked variant data for diagnosis and research »
  • Clara van Karnebeek, NL
  • Pierre-Emmanuel Gleizes, FR
  • Tudor Groza, UK « Rare disease patient stratification in primary care: Challenges and opportunities »
  • Kym Boycott, CAN

Poster Session A 17 to 18

Opening Ceremony, 18 to 19h30

  • Welcome message: Daria Julkowska (EJP RD), David Pierce (IRDiRC), Olivier Menzel (BLACKSWAN Foundation)
  • Ruxandra Draghia-Akli, USA
  • Gareth Baynam, AU

THURSDAY, MARCH 16th

Session B, 9 to 12, « Therapeutic Development, innovative clinical trials, precision medicine »

  • Marc Dooms, BE & Anneliene Jonker, NL « Devise – ways forward for medical devices for rare diseases »
  • Tim Buckinx, BE
  • Lucia Pannese, IT « Why Me? Tackling the Challenge of Rare Diseases through Gamification and Enabling Technologies »
  • Jose-Alain Sahel, USA « Developing Gene-Independent Approaches for Retinal Dystrophies »
  • Paulien Klap, NL « Developing an arm exoskeleton with the Duchenne Muscular Dystrophy community »

Lunch break and poster sessions B & C 12 to 13h30

Session C, 13h30 to 17, « Regulatory science »

  • Daniel O’Connor, UK
  • Anne Pariser, USA “Regulatory opportunities: Facilitating an environment of innovation”
  • Kerry Jo Lee, USA – FDA
  • Violeta Stoyanova-Beninska, NL – EMA
  • Julienne Vaillancourt, USA – FDA

FRIDAY, MARCH 17th

Session D, 9 to 12, « Clinical research »

  • Marta Alarcón-Riquelme, ES
  • Isabella Batsu, USA « Innovative clinical trial designs for rare diseases »
  • PJ Brooks, USA
  • Andrea Gropman, USA « From biomarker to study to basket clinical trials. Advancing science from the bedside or bench to trials: two models in academia »

Lunch break and poster sessions D, E & F 12 to 13h30

Session E, 13 to 17, « Gene and cell therapy »

  • Guillaume Canaud, FR « Targeted therapy for patients with PIK3CA-related overgrowth spectrum »
  • Laura de Rosa, IT « Combined cell & gene therapy for Epidermolysis Bullosa »
  • Arjan Lankester, NL « Lentiviral gene therapy in RAG1 severe combined immunodeficiency: experience from the multicenter RECOMB trial »
  • Fernardo Larcher, ES « Advances in cell and gene therapy for genodermatoses. A focus in Epidermolysis Bullosa. »
  • Carl Morris, USA
  • Julia Vitarello, USA

Social event, 18h30 To be confirmed

SATURDAY, MARCH 18th

Session F, 9 to 12, selected oral presentations and “Patients engagement and treatment access »

  • Mary Wang, IT
  • Samuel Agyei Wiafe, Ghana
  • Yarlalu Thomas, AU
  • Stefano Benvenuti

Best posters prize & Closing Ceremony  

 

Program updated January 27, 2023

Submenu
  • Full Program
  • Time table
Registration
Register !
To stay informed of our news, join our distribution list
Join !

Initiated by

Organized by

Partners

Previous congresses

2021
2019
2018
2016
2014
2012

Identity : Demian Conrad - Webdesign: Ergopix
  • Welcome
  • Attendees
    • Registration
    • Abstract information
    • Venue
    • Berlin
  • Program
    • Full Program
    • Time table
  • Speakers
  • Sponsors